Life Sciences

Life Sciences2018-09-12T14:34:35+00:00

Our Expertise

Artificial Intelligence (AI) is increasingly being used by biopharma companies to streamline the drug discovery process. AI algorithms can analyse and recognise patterns and trends in data sets from trials and studies at a faster rate than researchers, allowing hypotheses and drug discoveries to come about at expedited rates.

Increasing competition from outside technology companies, who are developing their own healthcare initiatives, has led to a rise in partnerships between tech and Life Science brands. These partnerships provide the Life Science companies with access to broader external expertise and technology not previously available.

Social media platforms are utilised by pharmaceutical companies to stimulate interest and enrolment in clinical trials, with a surge in geo-targeting and social media marketing to reach subjects and patients in a specific area or radius in order to recruit and spread awareness.

At fdu we understand the pace and depth of change in the Life Sciences sector, helping businesses innovate and excel in this exciting environment.

  • fdu has completed over 300 assignments to date
  • fdu has recruited for roles such as CFO and Finance Director in Life Sciences
  • fdu has supported over 12 Clients in this sector, a selection of which are featured below

Life Sciences Clients

Microtest
Role – CFO
Size – SME
Practice – Search

Read More

FirstKind
Role – CFO
Size – SME
Practice – Search

Read More
Proximagen
Role – FD
Size – SME
Practice – Search

Read More
Altimmune
Role – Interim Financial Controller
Size – SME
Practice – Interim

Read More

Kinapse
Role – Finance & Operations Director
Size – SME
Practice – Search

Read More

Soundbites

“We engaged fdu initially based on a recommendation and have gone back twice since – their network and effective screening enabled us to speed up recruitment and focus our time on interviewing the right candidates.”
Axel Thiemann, COO, Sonnedix Solar

“After spending many successful years with Proximagen, helping the company go through a flotation and subsequent sale, it was time for me to move on. I needed to find a Finance Director to replace me – one that was comfortable operating within the SME environment but also appreciated the requirements of reporting to a larger US parent company. Proximagen had been sold to Upsher-Smith Laboratories, so there was a requirement for the new Finance Director to help the local management team run and grow the company within the operating frameworks of the parent company. In fdu I found a search partner that was able to comprehensively scour the market place within the relevant industry sector, as well as a team that fully appreciated the need for a strong cultural fit. fdu’s timely and accurate advice made the process as seamless as possible and we were very pleased with the results.”

James Hunter, CFO, Breed Reply (previously Finance Director, Proximagen)